What Do the Trials Say for Catheter Ablation?-Anticoagulation Discontinuation After Successful Ablation: Where Are We and Where Are We Going (Presenter: Atul Verma, MD, FHRS)

Anticoagulation Discontinuation After Successful Ablation: Where Are We and Where Are We Going (Presenter: Atul Verma, MD, FHRS)

Back to course

Video Transcription

Video Summary

Dr. Atul Verma presented on the topic of anticoagulation discontinuation after successful ablation and the risks associated with it. He discussed the guidelines which recommend continuing oral anticoagulation after ablation, but noted the lack of trials supporting this recommendation. He presented data showing the ongoing risk of atrial fibrillation even after successful ablation, and questioned whether low burdens of AF actually increase the risk of stroke. Dr. Verma also mentioned a trial called OCEAN, which is investigating the most appropriate strategy for antithrombotic therapy post-ablation. He concluded by emphasizing the importance of individual patient risk factors in determining the need for continued anticoagulation.

Meta Tag

Lecture ID 4308

Location Room 303

Presenter Atul Verma, MD, FHRS

Role Invited Speaker

Session Date and Time May 10, 2019 10:30 AM - 12:00 PM

Session Number S-058

Keywords

anticoagulation discontinuation

ablation risks

oral anticoagulation

atrial fibrillation

stroke risk